Earlier this month, I was asked to participate in the panel discussion at the April OBN BioTuesday event, “What does it take for a biotech company to reach mid-size?” I joined Peter Nolan (CBO, Oxford BioMedica), who also hosted the event, as well as John Harris (CEO at OBN), Bill Fleming (CFO at Oxitec Ltd.) […]
About Daniela Weiss
This author has yet to write their bio.Meanwhile lets just say that we are proud Daniela Weiss contributed a whooping 14 entries.
Entries by Daniela Weiss
Gender diversity is always a hot topic of conversation. It's something that we feel somewhat responsible for as an executive search firm. In 2017, there are more women on boards than there has ever been. A step in the right direction but there’s still a way to go for diversity, especially in the pharmaceutical industry.
How diversity can improve the pharmaceutical industry
Gender diversity is so important for any workplace and not just in the interest of equality. Bringing females into more senior roles, alongside men, can change the way a business is run. As well as how decisions are made. A study by McKinsey found that gender diverse companies are 15% more likely to financially outperform those that are less diverse.Ultimately, having a diverse team can increase a business’ chance of success and therefore their bottom line.
Research shows that women bring a wealth of benefits to an organisation. From increasing productivity, improving reputations and decreasing turnover, a diverse workforce is a stronger one. Balance broadens perspectives and adds a breadth of insight that non-diverse workforces lack.
Balancing out gender diversity can help you connect better with your audience. Your customers are diverse, so should the decisions makers be. Ian Wilcox at the Hay Group suggested that having men dominating the industry creates a ‘blindspot’ that, unintentionally, gives priority to health issues more likely to affect men.
Improving diversity in pharmaceutical executive search
So, how do we achieve a balance in pharmaceutical roles? More pharmaceutical executive search firms need to take responsibility for diversity within candidate selection. Having a pool of talent that includes diversity in gender, ethnicity and experience is key. Getting a diverse offering through the door for senior and board level roles is a definite push in the right direction.
In order to further increase diversity in top roles, companies need to make senior and board roles available for females. Internal training and mentoring should be provided to encourage women to aim for seemingly unattainable roles.
More than half of the value of Chinese e-commerce is driven by mobile, and global brands in the country are adapting their strategy accordingly. L2’s Digital IQ Index®: Beauty China finds that the adoption of mobile-optimized sites by beauty brands has more than doubled year-over-year in 2015, driven mostly by foreign brands. Seventy percent of […]
Even if you read just the odd article about recruitment trends, you will probably have picked up on the discussions about how easy it has become to find candidates on LI and other networks, such as Xing, Viadeo, Ushi, etc. There is at times still a persistent notion that all the people a business wants […]
- LSX World Congress 2019 – feeling the pulse of the industry
- The European Life Sciences Market – continued growth despite the uncertainties of Brexit?
- Paul Edwards presents the ‘Best Established Biotech’ Award
- Make me a Vice President, and I’ll take the job!
- Should we recruit Rock Stars? – only if we can provide the right culture and leadership